Clinical trial to evaluate whether topical medication can prevent common skin cancer
A $34 million U.S. Veterans Affairs grant will enable Martin Weinstock, who directs dermatology research for the Providence V.A. and is a Brown professor, to evaluate the effectiveness of a common medication in preventing basal cell carcinoma.
PROVIDENCE, R.I. [Brown University]
Dr. Martin A. Weinstock, a professor of dermatology and epidemiology at Brown University, will lead a six-year clinical trial to evaluate the effectiveness of a topical medication as a way to prevent the most common type of cancer in the United States.
Backed by a $34 million award from the U.S. Department of Veterans Affairs Cooperative Studies Program, the study will investigate the potential of imiquimod, a topical medication with minimal side effects, as a preventive measure against basal cell carcinoma. Weinstock who is the chief of dermatology research for the V.A. Providence Healthcare System will lead the